Acute Coronary Syndrome. Acute coronary thrombosis not resulting in myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: For the intervention group, the sedation method will be performed by the researcher on the bed in Fatemeh Zahra Hospital in Sari. This intervention will be performe
so that the intervention group will receive sedation despite the standard treatment (injection of one gram of intravenous acetaminophen or Apotel) (9). Intervention 2: Control group: The control group
however, they will not receive any sedative intervention. Headache measurements in the control group will be performed similarly to those in the intervention group at 15, 35, and 60 minutes after the
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: A new diagnosis of ACS Age above 18 years No migraine headaches and any other headaches No drug addiction Absence of neurological disorders under drug treatment Absence of headache before starting nitroglycerin injection Absence of pain in other parts of the body (except chest pain) Absence of speech and vision disorders Not using oral and topical nitrate drugs
Exclusion criteria
Exclusion criteria: Lack of ability due to increased chest pain and confusion of the patient's hemodynamic symptoms (sbp<100, p<60) The need to increase the dose of nitroglycerin received (more than 5 micrograms per minute) Lack of cooperation with the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: For both the intervention and control groups, The first headache measurement will be done 15 minutes after the start of intravenous nitroglycerin infusion (before the intervention). The second measurement of headache will be done 35 minutes after the start of intravenous nitroglycerin infusion (immediately after the end of sedation) and the third measurement of headache will be done 60 minutes after the start of intravenous nitroglycerin infusion (after the intervention). Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Masoumeh Bagheri Nesami
Mazandaran University of Medical Sciences
Outcome results
None listed